Modular BSL Laboratory Strategy
Advisory support around modular and containerized laboratory pathways for research, surveillance, testing, and biocontainment programs where speed, flexibility, and phased deployment matter.
Industry Overview
Biotechnology capacity depends on infrastructure, trust, and long-term operating discipline
Biotechnology and biosafety programs succeed when scientific ambition is matched by practical delivery: fit-for-purpose facilities, strong operating protocols, credible partners, workforce training, and durable stakeholder alignment.
RBS helps clients move from concept to execution across modular and mobile laboratory strategies, disease-response platforms, research partnerships, and long-horizon ecosystem building. We are especially focused on sub-Saharan Africa, where resilient laboratory infrastructure and trusted partnerships can strengthen national preparedness, accelerate scientific capability, and improve response capacity over time.
Our approach is shaped by the reality that laboratory capability is not only a construction question. It is also an operating-system question: commissioning, biosafety workflows, maintenance planning, training pathways, regulatory coordination, and the credibility required to sustain public trust.
“I have to trust the scientific or medical communities’ conclusions.” — Sigal Ben-Porath, University of Pennsylvania
Strategic Priorities
Where organizations most often need support
In biotechnology and biosafety, the challenge is rarely just acquiring equipment. It is building a functioning capability that can operate reliably, compliantly, and sustainably.
Mobile Disease Surveillance Capacity
Planning for mobile laboratory capability in outbreak response, remote diagnostics, surge capacity, and field operations where deployability and containment are critical.
Biosecurity & Biosafety Infrastructure
Support on containment requirements, personnel flow, process design, operating protocols, and lifecycle realities in sensitive laboratory environments.
Biotechnology Partnership Structuring
Structuring relationships among manufacturers, ministries, universities, health systems, NGOs, and capital partners to support durable execution rather than one-off deployment.
Workforce & Operating Readiness
Planning for commissioning, training, validation, quality systems, service support, and long-term operational sustainability from the start.
Regional Stakeholder Alignment
Building trusted, long-term engagement across sub-Saharan Africa so projects are credible locally, useful operationally, and scalable over time.
Industry Context
Sub-Saharan Africa requires scalable, partnership-driven laboratory capacity
For many clients, the strategic challenge is not just acquiring a laboratory—it is deploying capability that can operate reliably across distance, infrastructure constraints, evolving public-health needs, and multi-institution stakeholder environments.
That is why RBS emphasizes modularity, mobility, and long-term relationship building. We believe the strongest biotechnology and biosafety programs are built around local relevance, operating credibility, and patient, trust-based partnerships that deepen over time rather than ending at installation.
How we frame the opportunity
- Align infrastructure choices with real operating environments and regional health priorities
- Build around commissioning, training, maintenance, and lifecycle sustainability
- Structure partnerships that endure beyond procurement and installation
- Support deployment strategies for both centralized and field-based laboratory capacity
- Connect biotechnology ambition to credible long-term execution
Advisory Lens
We view biotechnology and biosafety as strategic capacity, not just equipment procurement
The strongest biotechnology and biosecurity programs are not defined only by the laboratory shell. They are defined by how well infrastructure, operating models, partnerships, training, and mission objectives fit together. RBS helps clients design that full system—so the result is not just a facility, but a functioning capability.
Perspective
Long-term health security depends on long-term partnership
“Disease knows no borders.”
That principle should shape how leaders think about biotechnology, biosafety, and disease-response capability—especially in sub-Saharan Africa, where resilient, partnership-driven systems can have outsized strategic impact.